Treatment Options for Stage IV COPD

Doctor Auscultating a patient
Universal Images Group / Getty Images

Chronic obstructive pulmonary disease (COPD) is an inflammatory disorder of the lungs that restricts airflow into and out of the lungs. COPD is classified by stages of disease which help us determine the best course of treatment and predict the likely outcome (prognosis) of the disease.

Stage IV is considered the most severe form of COPD and is characterized by the severe shortness of breath (dyspnea). At this stage, your medication won't work as well as they used to, simple tasks will leave you breathless, and you will have an increased risk of lung infection, breathing problems, and respiratory failure.

Because COPD is irreversible, this stage of the disease is often referred to as "end stage COPD." This doesn't mean there aren't ways to treat the condition. The Global Initiative for Obstructive Lung Disease (GOLD) recommends the use of the following therapies and practices to best manage stage IV COPD.

Quitting Cigarettes

Quitting smoking is one way to live better.
Diane Macdonald/Getty Images

Even if you are diagnosed with advanced COPD, it's never too late to reap the rewards of smoking cessation. Not only does quitting help slow progression of the disease, the health benefits only continue to increase as time goes by.

After about two weeks, the worst of the nicotine withdrawal symptoms will begin to subside. Over the next few months, the risk of heart attack declines as your circulation improves.

After six to nine months, you'll start to feel less shortness of breath and have fewer problems with sinus congestion.

Flu and Pneumonia Vaccines

woman getting flu shot
Blend Images / Getty Images

Flu and pneumonia vaccines are among the GOLD treatment guidelines for every stage of the disease. Annual flu shots help people reduce the risk of COPD exacerbation while the pneumonia vaccine significantly decreases your chance of getting bacterial pneumonia.

Studies have shown the annual flu shot alone lowers the risk of illness and death in people with COPD by as much as 50 percent.

Short-Acting Bronchodilators

Woman using a bronchodilator, France
BSIP/UIG / Getty Images

Rescue inhalers, containing short-acting bronchodilators like Proventil (albuterol), help people with COPD manage persistent or worsening symptoms of the dise ase. These medications are part of the standard of care for all stages of COPD.

Albuterol is a beta-agonist-class drug which helps the muscles around your airways relax. Proventil is most often used to treat sudden episodes of shortness of breath related to bronchospasm.

Long-Acting Bronchodilators

Senior man about to use asthma inhaler
Martin Barraud / Getty Images

As your COPD progresses, your doctor may add one or more long-acting bronchodilators to help prevent or reduce the appearance of symptoms. While using only one long-acting bronchodilator is safe, combination therapy is often more effective with equal of fewer side effects.

Long-acting beta-agonists are one type of bronchodilator containing medications like salmeterol or formoterol. Long-acting anticholinergics are another type using Atrovent, Spiriva, or Combivent.

Pulmonary Rehabilitation

Physical therapist working with a patient.
Hero Images / Getty Images

Pulmonary rehabilitation is generally added during stage II COPD and continued as the disease progresses. It includes exercise, relaxation breathing techniquesnutritional advice, and emotional support to help people better cope with their condition.

Pulmonary rehab can help reduce ​disease symptoms, improve the quality of life, decrease social isolation, and increase survival time. The program uses a multidisciplinary team of nurses, physical and occupational therapists, dieticians, and counselors.

Steroid Medications

Man taking a pill.
Paul Bradbury/OJO Images/Getty Images

Treatment with glucocorticoids (commonly known as steroids) is controversial, but GOLD recommends them in the inhaled form once you reach Stage III and are suffering from frequent exacerbations.

Oral steroids may be used to treat COPD when symptoms rapidly get worse. Inhaled steroids, by contrast, are typically used to treat stable symptoms or when symptoms are slowly getting worse.

Oxygen Therapy

Oxygen Therapy
Science Photo Library/Getty Images

Oxygen therapy is recommended in stage IV on either a continuous basis, during exercise, and/or to relieve sudden episodes of dyspnea.

Continuous oxygen is generally recommended for those whose PaO2 (as measured by arterial blood gases) is 55 mm HG or less or whose oxygen saturation levels are less than or equal to 88 percent.

Lung Surgery

Surgeons performing surgery in operating room
Morsa Images / Getty Images

There are three types of lung surgery available to those who meet very specific criteria with stage IV COPD. They include a bullectomy used to treat large air spaces in the lung, lung volume reduction surgery (LVRS) used to remove a diseased lung, and lung transplantation.

Postoperative complications are common, particularly in those who are obese, in poor health, are elderly, or smoke.

Good Nutrition High in Calories

food from every food group on a table
Brett Stevens / Getty Images

Good nutrition is especially important for people with stage IV COPD as the disease places enormous stress on the body and effectively burns up all of the fuel you get from eating. As such, people with COPD will need to increase their caloric intake, ideally with healthy foods rich in antioxidants and phytochemicals.

Eating right can also bolster your immune system and, in turn, help fight chest infections common in people with COPD.

Was this page helpful?
Article Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. Papandrinopoulou D, Tzouda V, Tsoukalas G. Lung compliance and chronic obstructive pulmonary diseasePulm Med. 2012;2012:542769. doi:10.1155/2012/542769

  2. Qureshi H, Sharafkhaneh A, Hanania NA. Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implicationsTher Adv Chronic Dis. 2014;5(5):212–227. doi:10.1177/2040622314532862

  3. Devine JF. Chronic obstructive pulmonary disease: an overviewAm Health Drug Benefits. 2008;1(7):34–42. PMID: 25126252

  4. Patel AR, Patel AR, Singh S, Singh S, Khawaja I. Global Initiative for Chronic Obstructive Lung Disease: The Changes MadeCureus. 2019;11(6):e4985. Published 2019 Jun 24. doi:10.7759/cureus.4985

  5. Wu J, Sin DD. Improved patient outcome with smoking cessation: when is it too late?Int J Chron Obstruct Pulmon Dis. 2011;6:259–267. doi:10.2147/COPD.S10771

  6. Prochaska JJ, Benowitz NL. Smoking cessation and the cardiovascular patientCurr Opin Cardiol. 2015;30(5):506–511. doi:10.1097/HCO.0000000000000204

  7. Restrepo MI, Sibila O, Anzueto A. Pneumonia in Patients with Chronic Obstructive Pulmonary DiseaseTuberc Respir Dis (Seoul). 2018;81(3):187–197. doi:10.4046/trd.2018.0030

  8. Kopsaftis Z, Wood-Baker R, Poole P. Influenza vaccine for chronic obstructive pulmonary disease (COPD)Cochrane Database Syst Rev. 2018;6(6):CD002733. Published 2018 Jun 26. doi:10.1002/14651858.CD002733.pub3

  9. Kopsaftis ZA, Sulaiman NS, Mountain OD, Carson-Chahhoud KV, Phillips PA, Smith BJ. Short-acting bronchodilators for the management of acute exacerbations of chronic obstructive pulmonary disease in the hospital setting: systematic reviewSyst Rev. 2018;7(1):213. Published 2018 Nov 29. doi:10.1186/s13643-018-0860-0

  10. Billington CK, Penn RB, Hall IP. β2 AgonistsHandb Exp Pharmacol. 2017;237:23–40. doi:10.1007/164_2016_64

  11. Tashkin DP, Fabbri LM. Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agentsRespir Res. 2010;11(1):149. Published 2010 Oct 29. doi:10.1186/1465-9921-11-149

  12. Tashkin DP, Ferguson GT. Combination bronchodilator therapy in the management of chronic obstructive pulmonary diseaseRespir Res. 2013;14(1):49. Published 2013 May 8. doi:10.1186/1465-9921-14-49

  13. Corhay JL, Dang DN, Van Cauwenberge H, Louis R. Pulmonary rehabilitation and COPD: providing patients a good environment for optimizing therapyInt J Chron Obstruct Pulmon Dis. 2014;9:27–39. doi:10.2147/COPD.S52012

  14. Gensler LS. Glucocorticoids: complications to anticipate and preventNeurohospitalist. 2013;3(2):92–97. doi:10.1177/1941874412458678

  15. Wilkie M, Finch S, Schembri S. Inhaled Corticosteroids for Chronic Obstructive Pulmonary Disease--The Shifting Treatment ParadigmCOPD. 2015;12(5):582–590. doi:10.3109/15412555.2014.995288

  16. McDonald CF. Oxygen therapy for COPDJ Thorac Dis. 2014;6(11):1632–1639. doi:10.3978/j.issn.2072-1439.2014.10.23

  17. Brill SE, Wedzicha JA. Oxygen therapy in acute exacerbations of chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis. 2014;9:1241–1252. Published 2014 Nov 7. doi:10.2147/COPD.S41476

  18. Meyers BF, Patterson GA. Chronic obstructive pulmonary disease. 10: Bullectomy, lung volume reduction surgery, and transplantation for patients with chronic obstructive pulmonary diseaseThorax. 2003;58(7):634–638. doi:10.1136/thorax.58.7.634

  19. Licker M, Schweizer A, Ellenberger C, Tschopp JM, Diaper J, Clergue F. Perioperative medical management of patients with COPDInt J Chron Obstruct Pulmon Dis. 2007;2(4):493–515. PMID:18268924

  20. Rawal G, Yadav S. Nutrition in chronic obstructive pulmonary disease: A reviewJ Transl Int Med. 2015;3(4):151–154. doi:10.1515/jtim-2015-0021

  21. Lange P. Chronic obstructive pulmonary disease and risk of infection. Pneumonol Alergol Pol. 2009;77(3):284-8. PMID:19591100

Additional Reading